Methyl 2-Bromo-3-[4-[2-(5-Ethylpyridin-2-yl)ethoxy]phenyl]propanoate
Methyl 2-Bromo-3-[4-[2-(5-Ethylpyridin-2-yl)ethoxy]phenyl]propanoate (CAS: 105355-25-7) is a brominated ester intermediate featuring an activated alpha-bromo ester functionality on a complex biaryl ether framework. This compound serves as a strategic building block in the synthesis of thiazolidinedione antidiabetic agents, where the bromine undergoes nucleophilic displacement to construct the thiazolidine-2,4-dione ring characteristic of glitazone drugs. The ethylpyridyl ethoxy phenyl moiety provides the lipophilic pharmacophore essential for PPAR-gamma receptor binding, while the methyl ester offers a handle for subsequent transformations. Manufactured under strict quality controls to ensure high purity and minimal stereochemical impurities, this intermediate enables efficient assembly of high-value pharmaceutical actives. Proper storage in cool, dry conditions preserves its reactivity for demanding multi-step synthetic sequences.
– Glitazone Synthesis: Used as a key brominated intermediate in manufacturing pioglitazone and related thiazolidinedione antidiabetic drugs.
– Ring Construction: The alpha-bromo ester enables thiazolidinedione ring formation through condensation with thiourea derivatives.
– API Process Development: Serves in route optimization and scale-up for PPAR agonist pharmaceutical production.
– Medicinal Chemistry: Applied in developing novel insulin sensitizers and metabolic disease therapeutics.
Product Name: Methyl 2-Bromo-3-[4-[2-(5-Ethylpyridin-2-yl)ethoxy]phenyl]propanoate
For global customers, we provide complete technical documentation to support product evaluation, regulatory compliance and safe handling during transportation and application.